Pure Global AI
NCT05750654Not yet recruiting

Effectiveness of Small Phlebotomy Tubes in Reducing Blood Transfusions in Adult Medical Intensive Care Unit and Intermediate Care Unit Patients With Anemia

Effectiveness of Small Phlebotomy Tubes in Reducing Blood Transfusions in Adult Medical Intensive Care Unit and Intermediate Care Unit Patients With Anemia: A Randomized Controlled Trial
The University of Texas Health Science Center, HoustonClinicalTrials.govdeviceDevice trial
Verified
Study focus
Disease/Condition
Anemia
Drug/Device/Intervention
Small Phlebotomy Tube Group
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
The University of Texas Health Science Center, Houston
Location
Houston, United States of America
Timeline & enrollment
Phase
N/A
Start date
Apr 01, 2023
End date
Jul 31, 2025
Enrollment
688 participants
Primary outcome

Number of participants that receive a red blood cell (RBC) transfusion during hospitalization

Summary

The purpose of this study is to evaluate the effectiveness of small phlebotomy tubes to
 reduce RBC transfusions in medical intensive care unit (ICU) and Intermediate care unit (IMU)
 patients with low hemoglobin compared with standard size tubes, to compare the intervention
 and the control groups in regards to: ICU length of stay (LOS), ICU mortality, hospital LOS,
 and hospital mortality and to assess the acceptability of small phlebotomy tubes in adult ICU
 and IMU patients.

ICD-10 classifications
Anaemia, unspecifiedOther anaemiasOther specified anaemiasIron deficiency anaemiaIron deficiency anaemia, unspecified
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05750654
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT05750654 through Pure Global AI's free database. This phase not specified trial is sponsored by The University of Texas Health Science Center, Houston and is currently Not yet recruiting. The study focuses on Anemia. Target enrollment is 688 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.